On October 20, 2025, Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) announced the kickoff of its sixth spider silk production cycle for 2025. The company highlighted the first large‑scale deployment of its BAM‑1 Alpha hybrid, the newest evolution of its recombinant spider silk technology. The launch marks a significant operational milestone as the company expands its production capacity.
BAM‑1 Alpha builds directly on the 2024 breakthroughs, delivering stronger performance and higher silk yields while remaining fully aligned with Kraig’s aggressive production schedule. The hybrid incorporates diapause egg management, enabling greater production efficiency, smoother logistics, and sustained throughput across multiple cycles. The company reports that the transition to the more advanced hybrid requires no changes to its production schedule or rearing infrastructure, simply delivering more spider silk per cycle.
The deployment of BAM‑1 Alpha positions Kraig Labs to accelerate its commercial expansion and meet growing demand for high‑performance, sustainable fibers, aligning with its planned commercial deliveries to major global brands in the second half of 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.